KESAVA REDDY: ASSOCIATE DIRECTOR OF MEDICAL RESEARCH

Dr. Kesava Reddy works in association with Dr. Mark D’Andrea at University Cancer Centers and conducts clinical research, creates institutional review board protocols, and provides data analysis and interpretation of complex clinical data.

He was an Assistant Professor at the University of Kansas Medical Center in Kansas City, KS, for 13 years. He received his Ph.D. in Biochemistry from the University of Madras, India, and his Masters in Health Services Administration from the University of Kansas.

­­­­­­­­­­­­­­­­ PUBLICATIONS

Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus
Ventriculoperitoneal shunt surgery outcome in adult transition patients with pediatric-onset hydrocephalus
Ventriculoperitoneal shunt surgery and the incidence of shunt revision in adult patients with hemorrhage-related hydrocephalus.
2012 Nov
Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience
Ventriculoperitoneal shunt complications in hydrocephalus patients with intracranial tumors: an analysis of relevant risk factors
Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?
Management of adult hydrocephalus with ventriculoperitoneal shunts: long-term single-institution experience.
Obstructive hydrocephalus in adult patients: the Louisiana State University Health Sciences Center-Shreveport experience with ventriculoperitoneal shunts
Clinicalutility of microarray-derived genetic signatures in predicting outcomes in prostate cancer.
Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinoma.
Sorafenib: recent update on activity as a single agent and in combination with interferon-alpha2 in patients with advanced-stage renal cell carcinoma.
Prognostic significance of increasing lymph node count in stage III colorectal cancer.
The role of immunotherapy in the treatment of colorectal cancer.
Clinical utility of novel agents in the treatment of central venous catheter occlusion.
Optimizing the management of treatment-related peripheral neuropathy in patients with multiple myeloma.
Novel approaches in the management of myeloma-related skeletal complications.
The Role of Plerixafor (AMD3100) in Mobilizing Hematopoietic Progenitor Cells in Patients with Hematologic Malignancies.
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
2006 Apr
Denosumab (AMG 162), a Fully Human Monoclonal Antibody Against RANK Ligand Activity.
Role of prophylactic quinolones in reducing febrile neutropenia in patients undergoing myelosuppressive chemotherapy.
Palifermin is efficacious in reducing oral mucositis induced by intensive cancer therapy.
Impact of erythropoietic agents on survival of anemic patients with cancer.
Pegfilgrastim: recent advances in the prophylaxis of chemotherapy-induced neutropenia.
Role of epidermal growth factor receptor mutations in predicting sensitivity or resistance to targeted agents in non-small-cell lung cancer.
Noninvasive visualization of apoptosis using radiolabeled annexin v could predict response to chemotherapy.
Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer.
Paclitaxel poliglumex/carboplatin is similar to paclitaxel/carboplatin as first-line treatment in elderly patients with advanced non-small-cell lung cancer and a poor performance status.
Capecitabine/Oxaliplatin combinations in advanced colorectal cancer: summary of recent randomized studies.
Preoperative chemoradiation therapy shows improved clinical benefit in patients with rectal cancer.
Recent data with oxaliplatin-containing regimens in the adjuvant treatment of colorectal cancer.
Evolution of FOLFOX regimens in the treatment of advanced colorectal cancer.
Intergroup trial fails to demonstrate a benefit with the addition of irinotecan to bolus 5-fluorouracil/leucovorin in stage III colon cancer.
Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial.
New developments with bortezomib in treating multiple myeloma.
2004 Mar
Abarelix (Plenaxis): a gonadotropin-releasing hormone antagonist for medical castration in patients with advanced prostate cancer.
Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.
Kyphoplasty in the management of cancer-associated vertebral compression fractures.
Current strategies to minimize treatment-associated hot flashes in patients with breast cancer.
Incidence of thromboembolism and role of low molecular weight heparin in prolonging survival in patients with advanced malignancies.
AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats.
Photobiological basis and clinical role of low-intensity lasers in biology and medicine.
Comparison of the photostimulatory effects of visible He-Ne and infrared Ga-As lasers on healing impaired diabetic rat wounds.
Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues.
Glycation-induced matrix stability in the rabbit achilles tendon.
Photoactivated coumaryl-diazopyruvate fluorescent label for amine functional groups of tissues containing type-I collagen.
Laser photostimulation accelerates wound healing in diabetic rats.
The biomechanical integrity of bone in experimental diabetes.
Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes.
Matrix remodeling in healing rabbit Achilles tendon.
Laser photostimulation of collagen production in healing rabbit Achilles tendons.
Biochemistry and biomechanics of healing tendon: Part I. Effects of rigid plaster casts and functional casts.
Biochemistry and biomechanics of healing tendon: Part II. Effects of combined laser therapy and electrical stimulation.
Combined ultrasound, electrical stimulation, and laser promote collagen synthesis with moderate changes in tendon biomechanics.
A simplified method for the analysis of hydroxyproline in biological tissues.
Structure and composition of type IV collagen of bovine aorta.
Reductive cleavage of the disulfide bonds of the collagen IV noncollagenous domain in aqueous sodium dodecyl sulfate: absence of intermolecular nondisulfide cross-links.
Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody.
Neoplastic association of enhanced type V collagen production in rat fibrosarcoma.
Purification and characterization of collagens from rat fibrosarcoma induced by 3-methylcholanthrene.
Purification and characterization of recombinant porcine prorelaxin expressed in Escherichia coli.
Purification and characterization of collagenolytic property of renal cathepsin L from arthritic rat.
Metabolic studies on connective tissue collagens in bone and tendon of adjuvant arthritic rat.
Connective tissue metabolism in bone and cartilage of adjuvant arthritic rat.
Metabolism of glycosaminoglycans in tissues of adjuvant arthritic rat.
Molecular characteristics of soluble arthritic collagens.
Metabolism of collagen in bone of adjuvant induced arthritic rat.
Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents.
Studies on carbohydrate moieties of glycoproteins in established adjuvant induced arthritis.
Effect of a new non-steroidal anti-inflammatory agent on lysosomal stability in adjuvant induced arthritis.
Urinary excretion of connective tissue metabolites under the influence of a new non-steroidal anti-inflammatory agent in adjuvant induced arthritis.

EASY ONLINE APPOINTMENTS